Company intelligence / Profile preview

CKC Advisory

Sydney, New South Wales, Australiaeconomictimes.indiatimes.com ↗

Ownership: Private
Employees: ~14
Development stage: Other

Overview

Brandwood CKC—sometimes informally referenced as 'CKC Advisory' but officially known as 'Brandwood CKC'—is an Australian-headquartered consultancy specializing in regulatory affairs for medical devices and pharmaceuticals. It provides strategic guidance on product development/testing/regulatory submissions/postmarket compliance/reimbursement strategies primarily within Australia/New Zealand/APAC but also serves global clients seeking market access there. The company was created via the merger of two leading consultancies around late 2019–early 2020 and was acquired by global life sciences consultancy group PharmaLex in April 2021 to strengthen their regional footprint.

Industry: Consulting

Partnerships

PharmaLex Group

Beyond the preview

Go deeper on CKC Advisory.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CKC Advisory.

Explore the full profile